Neoleukin Therapeutics Price Prediction
| NLTXDelisted Stock | USD 13.96 0.16 1.16% |
Oversold Vs Overbought
42
Oversold | Overbought |
Neoleukin Therapeutics stock price prediction is an act of determining the future value of Neoleukin Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Neoleukin Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Neoleukin Therapeutics and does not consider all of the tangible or intangible factors available from Neoleukin Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Neoleukin Therapeutics, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether delisted stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Neoleukin Therapeutics based on different types of headlines from major news networks to social media. The Neoleukin stock price prediction module provides an analysis of price elasticity to changes in media outlook on Neoleukin Therapeutics over a specific investment horizon. Using Neoleukin Therapeutics hype-based prediction, you can estimate the value of Neoleukin Therapeutics from the perspective of Neoleukin Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Neoleukin Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Neoleukin Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Neoleukin because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Neoleukin Therapeutics after-hype prediction price | USD 13.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neoleukin |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neoleukin Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neoleukin Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Neoleukin Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Neoleukin Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Neoleukin Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Neoleukin Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Neoleukin Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Neoleukin Therapeutics' historical news coverage. Neoleukin Therapeutics' after-hype downside and upside margins for the prediction period are 13.96 and 13.96, respectively. We have considered Neoleukin Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Neoleukin Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Neoleukin Therapeutics is based on 3 months time horizon.
Neoleukin Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Neoleukin Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neoleukin Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neoleukin Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 2 Events / Month | 6 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
13.96 | 13.96 | 0.00 |
|
Neoleukin Therapeutics Hype Timeline
Neoleukin Therapeutics is now traded for 13.96. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Neoleukin is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Neoleukin Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 13.96. About 16.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neoleukin Therapeutics recorded a loss per share of 12.28. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 19th of December 2023. Given the investment horizon of 90 days the next anticipated press release will be in a few days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.Neoleukin Therapeutics Related Hype Analysis
Having access to credible news sources related to Neoleukin Therapeutics' direct competition is more important than ever and may enhance your ability to predict Neoleukin Therapeutics' future price movements. Getting to know how Neoleukin Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Neoleukin Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CTMX | CytomX Therapeutics | 0.01 | 9 per month | 3.83 | 0.02 | 8.16 | (5.80) | 50.71 | |
| SPRO | Spero Therapeutics | 0.01 | 9 per month | 3.13 | (0) | 4.82 | (5.59) | 16.20 | |
| TIL | Instil Bio | (0.28) | 8 per month | 1.73 | 0.13 | 6.43 | (3.60) | 25.51 | |
| NXTC | NextCure | 0.15 | 4 per month | 4.65 | 0.1 | 8.13 | (7.93) | 32.17 | |
| ASMB | Assembly Biosciences | (0.32) | 7 per month | 3.24 | 0.14 | 6.39 | (4.63) | 19.82 | |
| ACHL | Achilles Therapeutics PLC | (0.02) | 10 per month | 5.99 | (0) | 9.56 | (9.02) | 38.89 | |
| NUVB | Nuvation Bio | 0.70 | 9 per month | 4.03 | 0.12 | 16.67 | (6.50) | 46.16 |
Neoleukin Therapeutics Additional Predictive Modules
Most predictive techniques to examine Neoleukin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neoleukin using various technical indicators. When you analyze Neoleukin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Neoleukin Therapeutics Predictive Indicators
The successful prediction of Neoleukin Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Neoleukin Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Neoleukin Therapeutics based on analysis of Neoleukin Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Neoleukin Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Neoleukin Therapeutics's related companies. Story Coverage note for Neoleukin Therapeutics
The number of cover stories for Neoleukin Therapeutics depends on current market conditions and Neoleukin Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neoleukin Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neoleukin Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Neoleukin Therapeutics Short Properties
Neoleukin Therapeutics' future price predictability will typically decrease when Neoleukin Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neoleukin Therapeutics often depends not only on the future outlook of the potential Neoleukin Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neoleukin Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 55.2 M | |
| Cash And Short Term Investments | 96.4 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Neoleukin Stock
If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |